nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—TBK1—glaucoma	0.262	0.417	CbGaD
Sunitinib—MYLK—glaucoma	0.262	0.417	CbGaD
Sunitinib—NTRK1—glaucoma	0.104	0.166	CbGaD
Sunitinib—SBK1—cornea—glaucoma	0.0067	0.0973	CbGeAlD
Sunitinib—FGFR2—cornea—glaucoma	0.00314	0.0457	CbGeAlD
Sunitinib—ERN1—endothelium—glaucoma	0.00208	0.0302	CbGeAlD
Sunitinib—GRK7—eye—glaucoma	0.00147	0.0214	CbGeAlD
Sunitinib—GRK7—retina—glaucoma	0.00146	0.0212	CbGeAlD
Sunitinib—MYLK—endothelium—glaucoma	0.00131	0.0191	CbGeAlD
Sunitinib—GRK1—eye—glaucoma	0.00106	0.0155	CbGeAlD
Sunitinib—GRK1—retina—glaucoma	0.00105	0.0153	CbGeAlD
Sunitinib—NIM1K—retina—glaucoma	0.00105	0.0153	CbGeAlD
Sunitinib—PIP4K2B—eye—glaucoma	0.00102	0.0148	CbGeAlD
Sunitinib—ERN1—connective tissue—glaucoma	0.000983	0.0143	CbGeAlD
Sunitinib—FLT4—endothelium—glaucoma	0.000941	0.0137	CbGeAlD
Sunitinib—SBK1—eye—glaucoma	0.000825	0.012	CbGeAlD
Sunitinib—SBK1—retina—glaucoma	0.000818	0.0119	CbGeAlD
Sunitinib—RPS6KA1—eye—glaucoma	0.000773	0.0112	CbGeAlD
Sunitinib—STK11—connective tissue—glaucoma	0.000753	0.0109	CbGeAlD
Sunitinib—FLT1—endothelium—glaucoma	0.000732	0.0106	CbGeAlD
Sunitinib—NUAK1—retina—glaucoma	0.000712	0.0104	CbGeAlD
Sunitinib—RPS6KA2—retina—glaucoma	0.000695	0.0101	CbGeAlD
Sunitinib—PKN1—eye—glaucoma	0.000691	0.01	CbGeAlD
Sunitinib—INSR—connective tissue—glaucoma	0.000687	0.00998	CbGeAlD
Sunitinib—PKN1—retina—glaucoma	0.000685	0.00995	CbGeAlD
Sunitinib—CSNK1G2—retina—glaucoma	0.000685	0.00995	CbGeAlD
Sunitinib—PRPF4—eye—glaucoma	0.000681	0.00989	CbGeAlD
Sunitinib—RPS6KA2—connective tissue—glaucoma	0.000676	0.00982	CbGeAlD
Sunitinib—PRPF4—retina—glaucoma	0.000675	0.0098	CbGeAlD
Sunitinib—PKN1—connective tissue—glaucoma	0.000666	0.00967	CbGeAlD
Sunitinib—STK39—eye—glaucoma	0.000662	0.00962	CbGeAlD
Sunitinib—STK39—retina—glaucoma	0.000656	0.00953	CbGeAlD
Sunitinib—CSNK2A1—retina—glaucoma	0.000647	0.0094	CbGeAlD
Sunitinib—MYLK—eye—glaucoma	0.000645	0.00937	CbGeAlD
Sunitinib—MYLK—retina—glaucoma	0.000639	0.00928	CbGeAlD
Sunitinib—CSNK2A1—connective tissue—glaucoma	0.000629	0.00914	CbGeAlD
Sunitinib—OXSR1—Hydrochlorothiazide—Diclofenamide—glaucoma	0.000628	0.196	CbGdCrCtD
Sunitinib—MYLK—connective tissue—glaucoma	0.000621	0.00903	CbGeAlD
Sunitinib—KDR—endothelium—glaucoma	0.000619	0.00899	CbGeAlD
Sunitinib—STK24—eye—glaucoma	0.000618	0.00898	CbGeAlD
Sunitinib—STK24—retina—glaucoma	0.000613	0.0089	CbGeAlD
Sunitinib—STK4—connective tissue—glaucoma	0.00061	0.00886	CbGeAlD
Sunitinib—HIPK3—retina—glaucoma	0.000593	0.00861	CbGeAlD
Sunitinib—PRPF4—Levobunolol—Carteolol—glaucoma	0.000586	0.183	CbGdCrCtD
Sunitinib—MAP4K1—retina—glaucoma	0.000581	0.00844	CbGeAlD
Sunitinib—HIPK3—connective tissue—glaucoma	0.000576	0.00837	CbGeAlD
Sunitinib—HIPK2—connective tissue—glaucoma	0.000576	0.00837	CbGeAlD
Sunitinib—TYRO3—connective tissue—glaucoma	0.000576	0.00837	CbGeAlD
Sunitinib—ALK—connective tissue—glaucoma	0.000576	0.00837	CbGeAlD
Sunitinib—STK3—eye—glaucoma	0.000559	0.00812	CbGeAlD
Sunitinib—ROCK1—eye—glaucoma	0.000552	0.00802	CbGeAlD
Sunitinib—KIT—endothelium—glaucoma	0.000548	0.00797	CbGeAlD
Sunitinib—ROCK1—retina—glaucoma	0.000547	0.00794	CbGeAlD
Sunitinib—ROCK1—connective tissue—glaucoma	0.000532	0.00772	CbGeAlD
Sunitinib—MERTK—eye—glaucoma	0.000526	0.00764	CbGeAlD
Sunitinib—MERTK—retina—glaucoma	0.000521	0.00757	CbGeAlD
Sunitinib—MAP3K12—eye—glaucoma	0.000509	0.00739	CbGeAlD
Sunitinib—MAP2K1—eye—glaucoma	0.000498	0.00724	CbGeAlD
Sunitinib—PRPF4—Levobunolol—Timolol—glaucoma	0.000498	0.156	CbGdCrCtD
Sunitinib—RPS6KA3—retina—glaucoma	0.000497	0.00722	CbGeAlD
Sunitinib—MAP4K4—connective tissue—glaucoma	0.000497	0.00722	CbGeAlD
Sunitinib—CSNK1A1—eye—glaucoma	0.000492	0.00714	CbGeAlD
Sunitinib—FLT3—connective tissue—glaucoma	0.00049	0.00712	CbGeAlD
Sunitinib—CLK1—eye—glaucoma	0.000489	0.0071	CbGeAlD
Sunitinib—CLK1—retina—glaucoma	0.000484	0.00704	CbGeAlD
Sunitinib—RPS6KA3—connective tissue—glaucoma	0.000483	0.00702	CbGeAlD
Sunitinib—MAP2K1—connective tissue—glaucoma	0.00048	0.00697	CbGeAlD
Sunitinib—CAMK2G—eye—glaucoma	0.00048	0.00697	CbGeAlD
Sunitinib—CLK1—connective tissue—glaucoma	0.000471	0.00684	CbGeAlD
Sunitinib—BMP2K—connective tissue—glaucoma	0.000462	0.00671	CbGeAlD
Sunitinib—FLT4—eye—glaucoma	0.000462	0.00671	CbGeAlD
Sunitinib—CSNK1E—retina—glaucoma	0.000452	0.00656	CbGeAlD
Sunitinib—PRKAA1—connective tissue—glaucoma	0.000451	0.00656	CbGeAlD
Sunitinib—PTK2B—connective tissue—glaucoma	0.000446	0.00648	CbGeAlD
Sunitinib—ULK3—eye—glaucoma	0.000439	0.00637	CbGeAlD
Sunitinib—ULK3—retina—glaucoma	0.000435	0.00632	CbGeAlD
Sunitinib—MAP3K7—retina—glaucoma	0.000428	0.00621	CbGeAlD
Sunitinib—TBK1—eye—glaucoma	0.000427	0.0062	CbGeAlD
Sunitinib—TYK2—eye—glaucoma	0.000424	0.00616	CbGeAlD
Sunitinib—TYK2—retina—glaucoma	0.00042	0.0061	CbGeAlD
Sunitinib—MAP3K2—connective tissue—glaucoma	0.00042	0.0061	CbGeAlD
Sunitinib—RPS6KB1—eye—glaucoma	0.00041	0.00596	CbGeAlD
Sunitinib—TYK2—connective tissue—glaucoma	0.000408	0.00593	CbGeAlD
Sunitinib—RPS6KB1—retina—glaucoma	0.000407	0.00591	CbGeAlD
Sunitinib—AXL—eye—glaucoma	0.000406	0.0059	CbGeAlD
Sunitinib—AXL—retina—glaucoma	0.000403	0.00585	CbGeAlD
Sunitinib—RPS6KB1—connective tissue—glaucoma	0.000395	0.00574	CbGeAlD
Sunitinib—RET—connective tissue—glaucoma	0.000393	0.00571	CbGeAlD
Sunitinib—AXL—connective tissue—glaucoma	0.000391	0.00569	CbGeAlD
Sunitinib—FGFR2—eye—glaucoma	0.000387	0.00563	CbGeAlD
Sunitinib—FGFR2—connective tissue—glaucoma	0.000373	0.00542	CbGeAlD
Sunitinib—JAK2—connective tissue—glaucoma	0.000371	0.0054	CbGeAlD
Sunitinib—FYN—connective tissue—glaucoma	0.000366	0.00532	CbGeAlD
Sunitinib—FLT1—eye—glaucoma	0.000359	0.00522	CbGeAlD
Sunitinib—FLT1—retina—glaucoma	0.000356	0.00517	CbGeAlD
Sunitinib—PRPF4—Hydrochlorothiazide—Diclofenamide—glaucoma	0.000349	0.109	CbGdCrCtD
Sunitinib—FLT1—connective tissue—glaucoma	0.000346	0.00503	CbGeAlD
Sunitinib—YES1—eye—glaucoma	0.000343	0.00498	CbGeAlD
Sunitinib—YES1—retina—glaucoma	0.00034	0.00494	CbGeAlD
Sunitinib—TAOK3—eye—glaucoma	0.000339	0.00492	CbGeAlD
Sunitinib—TAOK3—retina—glaucoma	0.000336	0.00488	CbGeAlD
Sunitinib—YES1—connective tissue—glaucoma	0.000331	0.0048	CbGeAlD
Sunitinib—TAOK3—connective tissue—glaucoma	0.000326	0.00474	CbGeAlD
Sunitinib—PDGFRA—connective tissue—glaucoma	0.000324	0.00471	CbGeAlD
Sunitinib—KDR—eye—glaucoma	0.000304	0.00441	CbGeAlD
Sunitinib—KDR—retina—glaucoma	0.000301	0.00437	CbGeAlD
Sunitinib—CSF1R—eye—glaucoma	0.000296	0.00431	CbGeAlD
Sunitinib—KDR—connective tissue—glaucoma	0.000293	0.00425	CbGeAlD
Sunitinib—CSF1R—connective tissue—glaucoma	0.000285	0.00415	CbGeAlD
Sunitinib—PTK2B—Pindolol—Carteolol—glaucoma	0.000273	0.0852	CbGdCrCtD
Sunitinib—PTK2B—Pindolol—Levobunolol—glaucoma	0.000273	0.0852	CbGdCrCtD
Sunitinib—PDGFRB—eye—glaucoma	0.000263	0.00382	CbGeAlD
Sunitinib—PTK2B—Pindolol—Metipranolol—glaucoma	0.00026	0.0813	CbGdCrCtD
Sunitinib—KIT—connective tissue—glaucoma	0.000259	0.00377	CbGeAlD
Sunitinib—PDGFRB—connective tissue—glaucoma	0.000253	0.00368	CbGeAlD
Sunitinib—PTK2B—Pindolol—Betaxolol—glaucoma	0.000182	0.0569	CbGdCrCtD
Sunitinib—CHEK2—Treprostinil—Latanoprost—glaucoma	0.000153	0.0477	CbGdCrCtD
Sunitinib—Anorexia—Pilocarpine—glaucoma	9.23e-05	0.000635	CcSEcCtD
Sunitinib—Hypersensitivity—Apraclonidine—glaucoma	9.2e-05	0.000634	CcSEcCtD
Sunitinib—Paraesthesia—Dorzolamide—glaucoma	9.2e-05	0.000633	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Brinzolamide—glaucoma	9.17e-05	0.000632	CcSEcCtD
Sunitinib—Pain—Brimonidine—glaucoma	9.17e-05	0.000632	CcSEcCtD
Sunitinib—Dyspnoea—Dorzolamide—glaucoma	9.13e-05	0.000629	CcSEcCtD
Sunitinib—Insomnia—Brinzolamide—glaucoma	9.11e-05	0.000627	CcSEcCtD
Sunitinib—Muscle spasms—Clonidine—glaucoma	9.11e-05	0.000627	CcSEcCtD
Sunitinib—Dyspnoea—Travoprost—glaucoma	9.09e-05	0.000626	CcSEcCtD
Sunitinib—Paraesthesia—Brinzolamide—glaucoma	9.04e-05	0.000623	CcSEcCtD
Sunitinib—Dyspepsia—Dorzolamide—glaucoma	9.02e-05	0.000621	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Timolol—glaucoma	8.98e-05	0.000619	CcSEcCtD
Sunitinib—Dyspnoea—Brinzolamide—glaucoma	8.98e-05	0.000618	CcSEcCtD
Sunitinib—Dyspepsia—Travoprost—glaucoma	8.98e-05	0.000618	CcSEcCtD
Sunitinib—Asthenia—Apraclonidine—glaucoma	8.96e-05	0.000617	CcSEcCtD
Sunitinib—Decreased appetite—Dorzolamide—glaucoma	8.9e-05	0.000613	CcSEcCtD
Sunitinib—Dyspepsia—Brinzolamide—glaucoma	8.86e-05	0.00061	CcSEcCtD
Sunitinib—Eye disorder—Betaxolol—glaucoma	8.85e-05	0.000609	CcSEcCtD
Sunitinib—Pruritus—Apraclonidine—glaucoma	8.84e-05	0.000609	CcSEcCtD
Sunitinib—Body temperature increased—Acetazolamide—glaucoma	8.83e-05	0.000608	CcSEcCtD
Sunitinib—Fatigue—Dorzolamide—glaucoma	8.83e-05	0.000608	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Pilocarpine—glaucoma	8.82e-05	0.000607	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Travoprost—glaucoma	8.81e-05	0.000606	CcSEcCtD
Sunitinib—Fatigue—Travoprost—glaucoma	8.79e-05	0.000605	CcSEcCtD
Sunitinib—Flushing—Betaxolol—glaucoma	8.79e-05	0.000605	CcSEcCtD
Sunitinib—Cardiac disorder—Betaxolol—glaucoma	8.79e-05	0.000605	CcSEcCtD
Sunitinib—Pain—Dorzolamide—glaucoma	8.76e-05	0.000603	CcSEcCtD
Sunitinib—Insomnia—Pilocarpine—glaucoma	8.75e-05	0.000603	CcSEcCtD
Sunitinib—Decreased appetite—Brinzolamide—glaucoma	8.75e-05	0.000603	CcSEcCtD
Sunitinib—Weight decreased—Timolol—glaucoma	8.75e-05	0.000602	CcSEcCtD
Sunitinib—Pain—Travoprost—glaucoma	8.72e-05	0.000601	CcSEcCtD
Sunitinib—Constipation—Travoprost—glaucoma	8.72e-05	0.000601	CcSEcCtD
Sunitinib—Hyperglycaemia—Timolol—glaucoma	8.72e-05	0.0006	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Brinzolamide—glaucoma	8.69e-05	0.000599	CcSEcCtD
Sunitinib—Paraesthesia—Pilocarpine—glaucoma	8.69e-05	0.000598	CcSEcCtD
Sunitinib—Asthenia—Bimatoprost—glaucoma	8.69e-05	0.000598	CcSEcCtD
Sunitinib—Fatigue—Brinzolamide—glaucoma	8.68e-05	0.000598	CcSEcCtD
Sunitinib—Angioedema—Clonidine—glaucoma	8.65e-05	0.000596	CcSEcCtD
Sunitinib—Dyspnoea—Pilocarpine—glaucoma	8.63e-05	0.000594	CcSEcCtD
Sunitinib—Pain—Brinzolamide—glaucoma	8.61e-05	0.000593	CcSEcCtD
Sunitinib—Depression—Timolol—glaucoma	8.59e-05	0.000592	CcSEcCtD
Sunitinib—Angiopathy—Betaxolol—glaucoma	8.59e-05	0.000592	CcSEcCtD
Sunitinib—Pruritus—Bimatoprost—glaucoma	8.57e-05	0.00059	CcSEcCtD
Sunitinib—Immune system disorder—Betaxolol—glaucoma	8.56e-05	0.000589	CcSEcCtD
Sunitinib—Diarrhoea—Apraclonidine—glaucoma	8.55e-05	0.000589	CcSEcCtD
Sunitinib—Mediastinal disorder—Betaxolol—glaucoma	8.54e-05	0.000588	CcSEcCtD
Sunitinib—Dyspepsia—Pilocarpine—glaucoma	8.52e-05	0.000587	CcSEcCtD
Sunitinib—Chills—Betaxolol—glaucoma	8.5e-05	0.000585	CcSEcCtD
Sunitinib—Arrhythmia—Betaxolol—glaucoma	8.46e-05	0.000583	CcSEcCtD
Sunitinib—Decreased appetite—Pilocarpine—glaucoma	8.41e-05	0.000579	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dorzolamide—glaucoma	8.38e-05	0.000577	CcSEcCtD
Sunitinib—Alopecia—Betaxolol—glaucoma	8.37e-05	0.000576	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Pilocarpine—glaucoma	8.36e-05	0.000575	CcSEcCtD
Sunitinib—Gastrointestinal pain—Travoprost—glaucoma	8.34e-05	0.000574	CcSEcCtD
Sunitinib—Mental disorder—Betaxolol—glaucoma	8.3e-05	0.000571	CcSEcCtD
Sunitinib—Constipation—Pilocarpine—glaucoma	8.28e-05	0.00057	CcSEcCtD
Sunitinib—Pain—Pilocarpine—glaucoma	8.28e-05	0.00057	CcSEcCtD
Sunitinib—Cough—Clonidine—glaucoma	8.26e-05	0.000569	CcSEcCtD
Sunitinib—Dizziness—Apraclonidine—glaucoma	8.26e-05	0.000569	CcSEcCtD
Sunitinib—Erythema—Betaxolol—glaucoma	8.25e-05	0.000568	CcSEcCtD
Sunitinib—Malnutrition—Betaxolol—glaucoma	8.25e-05	0.000568	CcSEcCtD
Sunitinib—Epistaxis—Timolol—glaucoma	8.13e-05	0.00056	CcSEcCtD
Sunitinib—Body temperature increased—Dorzolamide—glaucoma	8.1e-05	0.000558	CcSEcCtD
Sunitinib—Abdominal pain—Dorzolamide—glaucoma	8.1e-05	0.000558	CcSEcCtD
Sunitinib—Dysgeusia—Betaxolol—glaucoma	8.07e-05	0.000556	CcSEcCtD
Sunitinib—Arthralgia—Clonidine—glaucoma	8.06e-05	0.000555	CcSEcCtD
Sunitinib—Chest pain—Clonidine—glaucoma	8.06e-05	0.000555	CcSEcCtD
Sunitinib—Abdominal pain—Travoprost—glaucoma	8.06e-05	0.000555	CcSEcCtD
Sunitinib—Asthenia—Acetazolamide—glaucoma	8.02e-05	0.000552	CcSEcCtD
Sunitinib—Dizziness—Bimatoprost—glaucoma	8.01e-05	0.000552	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	8.01e-05	0.000551	CcSEcCtD
Sunitinib—Vomiting—Apraclonidine—glaucoma	7.94e-05	0.000547	CcSEcCtD
Sunitinib—Muscle spasms—Betaxolol—glaucoma	7.93e-05	0.000546	CcSEcCtD
Sunitinib—Gastrointestinal pain—Pilocarpine—glaucoma	7.91e-05	0.000545	CcSEcCtD
Sunitinib—Hypersensitivity—Brimonidine—glaucoma	7.9e-05	0.000544	CcSEcCtD
Sunitinib—Dry mouth—Clonidine—glaucoma	7.89e-05	0.000543	CcSEcCtD
Sunitinib—Bradycardia—Timolol—glaucoma	7.88e-05	0.000542	CcSEcCtD
Sunitinib—Dermatitis—Apraclonidine—glaucoma	7.87e-05	0.000542	CcSEcCtD
Sunitinib—Headache—Apraclonidine—glaucoma	7.83e-05	0.000539	CcSEcCtD
Sunitinib—Oedema—Clonidine—glaucoma	7.73e-05	0.000532	CcSEcCtD
Sunitinib—Asthenia—Brimonidine—glaucoma	7.7e-05	0.00053	CcSEcCtD
Sunitinib—Infection—Clonidine—glaucoma	7.68e-05	0.000529	CcSEcCtD
Sunitinib—Abdominal pain—Pilocarpine—glaucoma	7.65e-05	0.000527	CcSEcCtD
Sunitinib—Body temperature increased—Pilocarpine—glaucoma	7.65e-05	0.000527	CcSEcCtD
Sunitinib—Diarrhoea—Acetazolamide—glaucoma	7.65e-05	0.000526	CcSEcCtD
Sunitinib—Rash—Bimatoprost—glaucoma	7.64e-05	0.000526	CcSEcCtD
Sunitinib—Dermatitis—Bimatoprost—glaucoma	7.63e-05	0.000525	CcSEcCtD
Sunitinib—Oedema peripheral—Timolol—glaucoma	7.62e-05	0.000525	CcSEcCtD
Sunitinib—Anaemia—Betaxolol—glaucoma	7.62e-05	0.000525	CcSEcCtD
Sunitinib—Shock—Clonidine—glaucoma	7.6e-05	0.000524	CcSEcCtD
Sunitinib—Connective tissue disorder—Timolol—glaucoma	7.6e-05	0.000524	CcSEcCtD
Sunitinib—Pruritus—Brimonidine—glaucoma	7.59e-05	0.000522	CcSEcCtD
Sunitinib—Headache—Bimatoprost—glaucoma	7.59e-05	0.000522	CcSEcCtD
Sunitinib—Nervous system disorder—Clonidine—glaucoma	7.58e-05	0.000522	CcSEcCtD
Sunitinib—Thrombocytopenia—Clonidine—glaucoma	7.57e-05	0.000521	CcSEcCtD
Sunitinib—Hypersensitivity—Dorzolamide—glaucoma	7.55e-05	0.00052	CcSEcCtD
Sunitinib—Hypersensitivity—Travoprost—glaucoma	7.51e-05	0.000517	CcSEcCtD
Sunitinib—Skin disorder—Clonidine—glaucoma	7.51e-05	0.000517	CcSEcCtD
Sunitinib—Nausea—Apraclonidine—glaucoma	7.42e-05	0.000511	CcSEcCtD
Sunitinib—Hypersensitivity—Brinzolamide—glaucoma	7.42e-05	0.000511	CcSEcCtD
Sunitinib—Dizziness—Acetazolamide—glaucoma	7.39e-05	0.000509	CcSEcCtD
Sunitinib—Anorexia—Clonidine—glaucoma	7.37e-05	0.000507	CcSEcCtD
Sunitinib—Asthenia—Dorzolamide—glaucoma	7.35e-05	0.000506	CcSEcCtD
Sunitinib—Asthenia—Travoprost—glaucoma	7.32e-05	0.000504	CcSEcCtD
Sunitinib—Pruritus—Dorzolamide—glaucoma	7.25e-05	0.000499	CcSEcCtD
Sunitinib—Eye disorder—Timolol—glaucoma	7.23e-05	0.000498	CcSEcCtD
Sunitinib—Asthenia—Brinzolamide—glaucoma	7.23e-05	0.000497	CcSEcCtD
Sunitinib—ABCB1—retina—glaucoma	7.22e-05	0.00105	CbGeAlD
Sunitinib—Pruritus—Travoprost—glaucoma	7.22e-05	0.000497	CcSEcCtD
Sunitinib—Cough—Betaxolol—glaucoma	7.19e-05	0.000495	CcSEcCtD
Sunitinib—Nausea—Bimatoprost—glaucoma	7.19e-05	0.000495	CcSEcCtD
Sunitinib—Cardiac disorder—Timolol—glaucoma	7.18e-05	0.000494	CcSEcCtD
Sunitinib—Hypersensitivity—Pilocarpine—glaucoma	7.13e-05	0.000491	CcSEcCtD
Sunitinib—Pruritus—Brinzolamide—glaucoma	7.12e-05	0.000491	CcSEcCtD
Sunitinib—Vomiting—Acetazolamide—glaucoma	7.11e-05	0.000489	CcSEcCtD
Sunitinib—Dizziness—Brimonidine—glaucoma	7.09e-05	0.000488	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Clonidine—glaucoma	7.04e-05	0.000485	CcSEcCtD
Sunitinib—Angiopathy—Timolol—glaucoma	7.02e-05	0.000483	CcSEcCtD
Sunitinib—Myalgia—Betaxolol—glaucoma	7.02e-05	0.000483	CcSEcCtD
Sunitinib—Arthralgia—Betaxolol—glaucoma	7.02e-05	0.000483	CcSEcCtD
Sunitinib—Chest pain—Betaxolol—glaucoma	7.02e-05	0.000483	CcSEcCtD
Sunitinib—Diarrhoea—Dorzolamide—glaucoma	7.01e-05	0.000483	CcSEcCtD
Sunitinib—Headache—Acetazolamide—glaucoma	7e-05	0.000482	CcSEcCtD
Sunitinib—Insomnia—Clonidine—glaucoma	6.99e-05	0.000481	CcSEcCtD
Sunitinib—Immune system disorder—Timolol—glaucoma	6.99e-05	0.000481	CcSEcCtD
Sunitinib—Diarrhoea—Travoprost—glaucoma	6.98e-05	0.00048	CcSEcCtD
Sunitinib—Mediastinal disorder—Timolol—glaucoma	6.97e-05	0.00048	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	6.97e-05	0.00048	CcSEcCtD
Sunitinib—Asthenia—Pilocarpine—glaucoma	6.94e-05	0.000478	CcSEcCtD
Sunitinib—Paraesthesia—Clonidine—glaucoma	6.94e-05	0.000478	CcSEcCtD
Sunitinib—Arrhythmia—Timolol—glaucoma	6.91e-05	0.000476	CcSEcCtD
Sunitinib—Dyspnoea—Clonidine—glaucoma	6.89e-05	0.000474	CcSEcCtD
Sunitinib—Diarrhoea—Brinzolamide—glaucoma	6.89e-05	0.000474	CcSEcCtD
Sunitinib—Dry mouth—Betaxolol—glaucoma	6.87e-05	0.000473	CcSEcCtD
Sunitinib—Pruritus—Pilocarpine—glaucoma	6.85e-05	0.000471	CcSEcCtD
Sunitinib—Alopecia—Timolol—glaucoma	6.84e-05	0.000471	CcSEcCtD
Sunitinib—Mental disorder—Timolol—glaucoma	6.78e-05	0.000467	CcSEcCtD
Sunitinib—Dizziness—Dorzolamide—glaucoma	6.77e-05	0.000466	CcSEcCtD
Sunitinib—Rash—Brimonidine—glaucoma	6.76e-05	0.000466	CcSEcCtD
Sunitinib—Dermatitis—Brimonidine—glaucoma	6.76e-05	0.000465	CcSEcCtD
Sunitinib—Dizziness—Travoprost—glaucoma	6.74e-05	0.000464	CcSEcCtD
Sunitinib—Erythema—Timolol—glaucoma	6.74e-05	0.000464	CcSEcCtD
Sunitinib—Malnutrition—Timolol—glaucoma	6.74e-05	0.000464	CcSEcCtD
Sunitinib—Oedema—Betaxolol—glaucoma	6.73e-05	0.000463	CcSEcCtD
Sunitinib—Headache—Brimonidine—glaucoma	6.72e-05	0.000463	CcSEcCtD
Sunitinib—Decreased appetite—Clonidine—glaucoma	6.72e-05	0.000463	CcSEcCtD
Sunitinib—Infection—Betaxolol—glaucoma	6.69e-05	0.00046	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Clonidine—glaucoma	6.67e-05	0.000459	CcSEcCtD
Sunitinib—Fatigue—Clonidine—glaucoma	6.66e-05	0.000459	CcSEcCtD
Sunitinib—Dizziness—Brinzolamide—glaucoma	6.66e-05	0.000459	CcSEcCtD
Sunitinib—Nausea—Acetazolamide—glaucoma	6.64e-05	0.000457	CcSEcCtD
Sunitinib—Diarrhoea—Pilocarpine—glaucoma	6.62e-05	0.000456	CcSEcCtD
Sunitinib—Shock—Betaxolol—glaucoma	6.62e-05	0.000456	CcSEcCtD
Sunitinib—Constipation—Clonidine—glaucoma	6.61e-05	0.000455	CcSEcCtD
Sunitinib—Pain—Clonidine—glaucoma	6.61e-05	0.000455	CcSEcCtD
Sunitinib—Nervous system disorder—Betaxolol—glaucoma	6.6e-05	0.000454	CcSEcCtD
Sunitinib—Dysgeusia—Timolol—glaucoma	6.6e-05	0.000454	CcSEcCtD
Sunitinib—Thrombocytopenia—Betaxolol—glaucoma	6.59e-05	0.000454	CcSEcCtD
Sunitinib—Skin disorder—Betaxolol—glaucoma	6.54e-05	0.00045	CcSEcCtD
Sunitinib—Vomiting—Dorzolamide—glaucoma	6.51e-05	0.000448	CcSEcCtD
Sunitinib—Rash—Dorzolamide—glaucoma	6.46e-05	0.000445	CcSEcCtD
Sunitinib—Dermatitis—Dorzolamide—glaucoma	6.45e-05	0.000444	CcSEcCtD
Sunitinib—Rash—Travoprost—glaucoma	6.43e-05	0.000443	CcSEcCtD
Sunitinib—Dermatitis—Travoprost—glaucoma	6.42e-05	0.000442	CcSEcCtD
Sunitinib—Headache—Dorzolamide—glaucoma	6.42e-05	0.000442	CcSEcCtD
Sunitinib—Anorexia—Betaxolol—glaucoma	6.41e-05	0.000442	CcSEcCtD
Sunitinib—Vomiting—Brinzolamide—glaucoma	6.4e-05	0.000441	CcSEcCtD
Sunitinib—Dizziness—Pilocarpine—glaucoma	6.4e-05	0.000441	CcSEcCtD
Sunitinib—Headache—Travoprost—glaucoma	6.39e-05	0.00044	CcSEcCtD
Sunitinib—Nausea—Brimonidine—glaucoma	6.37e-05	0.000439	CcSEcCtD
Sunitinib—Rash—Brinzolamide—glaucoma	6.35e-05	0.000437	CcSEcCtD
Sunitinib—Dermatitis—Brinzolamide—glaucoma	6.34e-05	0.000437	CcSEcCtD
Sunitinib—Gastrointestinal pain—Clonidine—glaucoma	6.32e-05	0.000435	CcSEcCtD
Sunitinib—Headache—Brinzolamide—glaucoma	6.31e-05	0.000434	CcSEcCtD
Sunitinib—Angioedema—Timolol—glaucoma	6.15e-05	0.000424	CcSEcCtD
Sunitinib—Vomiting—Pilocarpine—glaucoma	6.15e-05	0.000424	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Betaxolol—glaucoma	6.13e-05	0.000422	CcSEcCtD
Sunitinib—Body temperature increased—Clonidine—glaucoma	6.11e-05	0.000421	CcSEcCtD
Sunitinib—Abdominal pain—Clonidine—glaucoma	6.11e-05	0.000421	CcSEcCtD
Sunitinib—Rash—Pilocarpine—glaucoma	6.1e-05	0.00042	CcSEcCtD
Sunitinib—Dermatitis—Pilocarpine—glaucoma	6.1e-05	0.00042	CcSEcCtD
Sunitinib—Insomnia—Betaxolol—glaucoma	6.09e-05	0.000419	CcSEcCtD
Sunitinib—Nausea—Dorzolamide—glaucoma	6.08e-05	0.000419	CcSEcCtD
Sunitinib—Headache—Pilocarpine—glaucoma	6.06e-05	0.000417	CcSEcCtD
Sunitinib—Nausea—Travoprost—glaucoma	6.06e-05	0.000417	CcSEcCtD
Sunitinib—Paraesthesia—Betaxolol—glaucoma	6.04e-05	0.000416	CcSEcCtD
Sunitinib—Dyspnoea—Betaxolol—glaucoma	6e-05	0.000413	CcSEcCtD
Sunitinib—Nausea—Brinzolamide—glaucoma	5.98e-05	0.000412	CcSEcCtD
Sunitinib—Dyspepsia—Betaxolol—glaucoma	5.92e-05	0.000408	CcSEcCtD
Sunitinib—Cough—Timolol—glaucoma	5.88e-05	0.000405	CcSEcCtD
Sunitinib—Decreased appetite—Betaxolol—glaucoma	5.85e-05	0.000403	CcSEcCtD
Sunitinib—Hypertension—Timolol—glaucoma	5.82e-05	0.0004	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Betaxolol—glaucoma	5.81e-05	0.0004	CcSEcCtD
Sunitinib—Fatigue—Betaxolol—glaucoma	5.8e-05	0.000399	CcSEcCtD
Sunitinib—Pain—Betaxolol—glaucoma	5.75e-05	0.000396	CcSEcCtD
Sunitinib—Constipation—Betaxolol—glaucoma	5.75e-05	0.000396	CcSEcCtD
Sunitinib—Nausea—Pilocarpine—glaucoma	5.75e-05	0.000396	CcSEcCtD
Sunitinib—Chest pain—Timolol—glaucoma	5.73e-05	0.000395	CcSEcCtD
Sunitinib—Myalgia—Timolol—glaucoma	5.73e-05	0.000395	CcSEcCtD
Sunitinib—Arthralgia—Timolol—glaucoma	5.73e-05	0.000395	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.7e-05	0.000392	CcSEcCtD
Sunitinib—Hypersensitivity—Clonidine—glaucoma	5.69e-05	0.000392	CcSEcCtD
Sunitinib—Dry mouth—Timolol—glaucoma	5.61e-05	0.000386	CcSEcCtD
Sunitinib—Asthenia—Clonidine—glaucoma	5.55e-05	0.000382	CcSEcCtD
Sunitinib—Oedema—Timolol—glaucoma	5.5e-05	0.000379	CcSEcCtD
Sunitinib—Pruritus—Clonidine—glaucoma	5.47e-05	0.000377	CcSEcCtD
Sunitinib—Infection—Timolol—glaucoma	5.46e-05	0.000376	CcSEcCtD
Sunitinib—Shock—Timolol—glaucoma	5.41e-05	0.000372	CcSEcCtD
Sunitinib—Nervous system disorder—Timolol—glaucoma	5.39e-05	0.000371	CcSEcCtD
Sunitinib—Skin disorder—Timolol—glaucoma	5.34e-05	0.000368	CcSEcCtD
Sunitinib—Body temperature increased—Betaxolol—glaucoma	5.32e-05	0.000366	CcSEcCtD
Sunitinib—Diarrhoea—Clonidine—glaucoma	5.29e-05	0.000364	CcSEcCtD
Sunitinib—Anorexia—Timolol—glaucoma	5.24e-05	0.000361	CcSEcCtD
Sunitinib—Dizziness—Clonidine—glaucoma	5.11e-05	0.000352	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Timolol—glaucoma	5.01e-05	0.000345	CcSEcCtD
Sunitinib—Insomnia—Timolol—glaucoma	4.97e-05	0.000342	CcSEcCtD
Sunitinib—Hypersensitivity—Betaxolol—glaucoma	4.96e-05	0.000341	CcSEcCtD
Sunitinib—Paraesthesia—Timolol—glaucoma	4.94e-05	0.00034	CcSEcCtD
Sunitinib—Vomiting—Clonidine—glaucoma	4.91e-05	0.000338	CcSEcCtD
Sunitinib—Dyspnoea—Timolol—glaucoma	4.9e-05	0.000337	CcSEcCtD
Sunitinib—Rash—Clonidine—glaucoma	4.87e-05	0.000336	CcSEcCtD
Sunitinib—Dermatitis—Clonidine—glaucoma	4.87e-05	0.000335	CcSEcCtD
Sunitinib—Headache—Clonidine—glaucoma	4.84e-05	0.000333	CcSEcCtD
Sunitinib—Dyspepsia—Timolol—glaucoma	4.84e-05	0.000333	CcSEcCtD
Sunitinib—Asthenia—Betaxolol—glaucoma	4.83e-05	0.000332	CcSEcCtD
Sunitinib—Decreased appetite—Timolol—glaucoma	4.78e-05	0.000329	CcSEcCtD
Sunitinib—Pruritus—Betaxolol—glaucoma	4.76e-05	0.000328	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Timolol—glaucoma	4.75e-05	0.000327	CcSEcCtD
Sunitinib—Fatigue—Timolol—glaucoma	4.74e-05	0.000326	CcSEcCtD
Sunitinib—Pain—Timolol—glaucoma	4.7e-05	0.000324	CcSEcCtD
Sunitinib—Diarrhoea—Betaxolol—glaucoma	4.6e-05	0.000317	CcSEcCtD
Sunitinib—Nausea—Clonidine—glaucoma	4.59e-05	0.000316	CcSEcCtD
Sunitinib—Gastrointestinal pain—Timolol—glaucoma	4.5e-05	0.00031	CcSEcCtD
Sunitinib—Dizziness—Betaxolol—glaucoma	4.45e-05	0.000306	CcSEcCtD
Sunitinib—Body temperature increased—Timolol—glaucoma	4.35e-05	0.000299	CcSEcCtD
Sunitinib—Abdominal pain—Timolol—glaucoma	4.35e-05	0.000299	CcSEcCtD
Sunitinib—Vomiting—Betaxolol—glaucoma	4.28e-05	0.000295	CcSEcCtD
Sunitinib—Rash—Betaxolol—glaucoma	4.24e-05	0.000292	CcSEcCtD
Sunitinib—Dermatitis—Betaxolol—glaucoma	4.24e-05	0.000292	CcSEcCtD
Sunitinib—Headache—Betaxolol—glaucoma	4.22e-05	0.00029	CcSEcCtD
Sunitinib—Hypersensitivity—Timolol—glaucoma	4.05e-05	0.000279	CcSEcCtD
Sunitinib—Nausea—Betaxolol—glaucoma	4e-05	0.000275	CcSEcCtD
Sunitinib—Asthenia—Timolol—glaucoma	3.94e-05	0.000272	CcSEcCtD
Sunitinib—Pruritus—Timolol—glaucoma	3.89e-05	0.000268	CcSEcCtD
Sunitinib—Diarrhoea—Timolol—glaucoma	3.76e-05	0.000259	CcSEcCtD
Sunitinib—Dizziness—Timolol—glaucoma	3.64e-05	0.00025	CcSEcCtD
Sunitinib—Vomiting—Timolol—glaucoma	3.5e-05	0.000241	CcSEcCtD
Sunitinib—Rash—Timolol—glaucoma	3.47e-05	0.000239	CcSEcCtD
Sunitinib—Dermatitis—Timolol—glaucoma	3.46e-05	0.000238	CcSEcCtD
Sunitinib—Headache—Timolol—glaucoma	3.44e-05	0.000237	CcSEcCtD
Sunitinib—Nausea—Timolol—glaucoma	3.27e-05	0.000225	CcSEcCtD
Sunitinib—FGFR1—Signaling Pathways—C3—glaucoma	1.75e-06	1.14e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—CDKN1B—glaucoma	1.75e-06	1.14e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—APOE—glaucoma	1.75e-06	1.14e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—C3—glaucoma	1.75e-06	1.13e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—NOS3—glaucoma	1.74e-06	1.13e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—NOS3—glaucoma	1.74e-06	1.13e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EDN1—glaucoma	1.74e-06	1.13e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CDKN1B—glaucoma	1.74e-06	1.13e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CAV1—glaucoma	1.73e-06	1.13e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—PTGS2—glaucoma	1.73e-06	1.13e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CA1—glaucoma	1.73e-06	1.13e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MMP9—glaucoma	1.73e-06	1.12e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EDN1—glaucoma	1.73e-06	1.12e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CDKN1B—glaucoma	1.72e-06	1.12e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CDKN1B—glaucoma	1.72e-06	1.12e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FN1—glaucoma	1.72e-06	1.12e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDKN2B—glaucoma	1.72e-06	1.12e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—APOE—glaucoma	1.72e-06	1.12e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—APOE—glaucoma	1.72e-06	1.12e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—PTGS2—glaucoma	1.71e-06	1.11e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—NOS3—glaucoma	1.7e-06	1.11e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—NOS3—glaucoma	1.7e-06	1.11e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CAV1—glaucoma	1.7e-06	1.11e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CAV1—glaucoma	1.7e-06	1.11e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—BAD—glaucoma	1.7e-06	1.1e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TP53—glaucoma	1.7e-06	1.1e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NGF—glaucoma	1.7e-06	1.1e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—PTGS2—glaucoma	1.68e-06	1.09e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CTSA—glaucoma	1.68e-06	1.09e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FN1—glaucoma	1.67e-06	1.08e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—NOS3—glaucoma	1.66e-06	1.08e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—GSTM1—glaucoma	1.66e-06	1.08e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NGF—glaucoma	1.66e-06	1.08e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—BAD—glaucoma	1.65e-06	1.07e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EDN1—glaucoma	1.65e-06	1.07e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FN1—glaucoma	1.65e-06	1.07e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—CDKN1B—glaucoma	1.64e-06	1.07e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—GSTM1—glaucoma	1.64e-06	1.07e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CDKN1B—glaucoma	1.64e-06	1.06e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CDKN1B—glaucoma	1.63e-06	1.06e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—APOE—glaucoma	1.63e-06	1.06e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—BAD—glaucoma	1.63e-06	1.06e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TP53—glaucoma	1.63e-06	1.06e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—APOE—glaucoma	1.63e-06	1.06e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MMP9—glaucoma	1.62e-06	1.05e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—CDKN1B—glaucoma	1.62e-06	1.05e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FN1—glaucoma	1.62e-06	1.05e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FN1—glaucoma	1.62e-06	1.05e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CAV1—glaucoma	1.62e-06	1.05e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.62e-06	1.05e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TP53—glaucoma	1.62e-06	1.05e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—C3—glaucoma	1.61e-06	1.05e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CAV1—glaucoma	1.61e-06	1.05e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MMP9—glaucoma	1.61e-06	1.04e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—NOS3—glaucoma	1.61e-06	1.04e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—BAD—glaucoma	1.6e-06	1.04e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—BAD—glaucoma	1.6e-06	1.04e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NGF—glaucoma	1.6e-06	1.04e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PTGS2—glaucoma	1.6e-06	1.04e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—CDKN1B—glaucoma	1.59e-06	1.03e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PTGS2—glaucoma	1.59e-06	1.03e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CDKN1B—glaucoma	1.59e-06	1.03e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NGF—glaucoma	1.59e-06	1.03e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CA2—glaucoma	1.59e-06	1.03e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—C3—glaucoma	1.57e-06	1.02e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—NOS3—glaucoma	1.57e-06	1.02e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—VEGFA—glaucoma	1.55e-06	1.01e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TP53—glaucoma	1.54e-06	1e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FN1—glaucoma	1.54e-06	9.99e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FN1—glaucoma	1.53e-06	9.96e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CDKN1B—glaucoma	1.53e-06	9.95e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—glaucoma	1.52e-06	9.9e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CDKN1B—glaucoma	1.52e-06	9.88e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—BAD—glaucoma	1.52e-06	9.87e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—C3—glaucoma	1.52e-06	9.85e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NGF—glaucoma	1.52e-06	9.85e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—BAD—glaucoma	1.52e-06	9.84e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CDKN1B—glaucoma	1.51e-06	9.81e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—NOS3—glaucoma	1.51e-06	9.81e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—C3—glaucoma	1.51e-06	9.8e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CDKN1B—glaucoma	1.51e-06	9.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CDKN1B—glaucoma	1.51e-06	9.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—NOS3—glaucoma	1.5e-06	9.76e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—APOE—glaucoma	1.5e-06	9.75e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CAV1—glaucoma	1.49e-06	9.66e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ABCA1—glaucoma	1.48e-06	9.64e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYP1B1—glaucoma	1.48e-06	9.64e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CDKN1B—glaucoma	1.48e-06	9.58e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CDKN1B—glaucoma	1.48e-06	9.58e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MMP9—glaucoma	1.47e-06	9.56e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CDKN1B—glaucoma	1.47e-06	9.55e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PTGS2—glaucoma	1.47e-06	9.54e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—APOE—glaucoma	1.47e-06	9.52e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—MTHFR—glaucoma	1.46e-06	9.5e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—VEGFA—glaucoma	1.46e-06	9.46e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—glaucoma	1.45e-06	9.43e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CAV1—glaucoma	1.45e-06	9.43e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—MTHFR—glaucoma	1.45e-06	9.42e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—VEGFA—glaucoma	1.44e-06	9.37e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—C3—glaucoma	1.44e-06	9.37e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—NOS3—glaucoma	1.44e-06	9.36e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CDKN1B—glaucoma	1.44e-06	9.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—NOS3—glaucoma	1.44e-06	9.33e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PTGS2—glaucoma	1.43e-06	9.31e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MMP9—glaucoma	1.42e-06	9.21e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—CDKN1B—glaucoma	1.42e-06	9.21e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FN1—glaucoma	1.42e-06	9.2e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—APOE—glaucoma	1.41e-06	9.17e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CDKN1B—glaucoma	1.41e-06	9.16e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MMP9—glaucoma	1.41e-06	9.15e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTT1—glaucoma	1.41e-06	9.13e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—APOE—glaucoma	1.4e-06	9.12e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CAV1—glaucoma	1.4e-06	9.09e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—BAD—glaucoma	1.4e-06	9.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CAV1—glaucoma	1.39e-06	9.04e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CDKN1B—glaucoma	1.39e-06	9.04e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PTGS2—glaucoma	1.38e-06	8.97e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FN1—glaucoma	1.38e-06	8.97e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PTGS2—glaucoma	1.37e-06	8.93e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—glaucoma	1.37e-06	8.89e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—NOS3—glaucoma	1.37e-06	8.88e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MMP9—glaucoma	1.37e-06	8.88e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MMP9—glaucoma	1.37e-06	8.88e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—BAD—glaucoma	1.37e-06	8.87e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—APOE—glaucoma	1.36e-06	8.85e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—glaucoma	1.36e-06	8.82e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CDKN1B—glaucoma	1.36e-06	8.82e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—APOE—glaucoma	1.35e-06	8.77e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—CAV1—glaucoma	1.35e-06	8.77e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CDKN1B—glaucoma	1.35e-06	8.75e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—APOE—glaucoma	1.34e-06	8.72e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—CAV1—glaucoma	1.34e-06	8.69e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP9—glaucoma	1.33e-06	8.65e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FN1—glaucoma	1.33e-06	8.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CAV1—glaucoma	1.33e-06	8.64e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—NOS3—glaucoma	1.33e-06	8.62e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FN1—glaucoma	1.32e-06	8.6e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—VEGFA—glaucoma	1.32e-06	8.59e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—BAD—glaucoma	1.32e-06	8.55e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PTGS2—glaucoma	1.31e-06	8.53e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—NOS3—glaucoma	1.31e-06	8.51e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—BAD—glaucoma	1.31e-06	8.5e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—CDKN1B—glaucoma	1.31e-06	8.5e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CDKN1B—glaucoma	1.3e-06	8.45e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—NOS3—glaucoma	1.29e-06	8.36e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—NOS3—glaucoma	1.29e-06	8.36e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—VEGFA—glaucoma	1.27e-06	8.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FN1—glaucoma	1.27e-06	8.22e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—VEGFA—glaucoma	1.27e-06	8.22e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—BAD—glaucoma	1.25e-06	8.12e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CDKN1B—glaucoma	1.25e-06	8.11e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—CDKN1B—glaucoma	1.24e-06	8.08e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—VEGFA—glaucoma	1.23e-06	7.97e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—VEGFA—glaucoma	1.23e-06	7.97e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NOS3—glaucoma	1.22e-06	7.93e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NOS3—glaucoma	1.22e-06	7.91e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—VEGFA—glaucoma	1.2e-06	7.77e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GSTM1—glaucoma	1.19e-06	7.7e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CDKN1B—glaucoma	1.18e-06	7.69e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—glaucoma	1.17e-06	7.62e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—glaucoma	1.16e-06	7.51e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CDKN1B—glaucoma	1.15e-06	7.47e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CDKN1B—glaucoma	1.14e-06	7.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NOS3—glaucoma	1.13e-06	7.31e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1B1—glaucoma	1.12e-06	7.27e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ABCA1—glaucoma	1.12e-06	7.27e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TXN—glaucoma	1.12e-06	7.25e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CDKN1B—glaucoma	1.12e-06	7.24e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CDKN1B—glaucoma	1.12e-06	7.24e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—glaucoma	1.1e-06	7.15e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NOS3—glaucoma	1.1e-06	7.13e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP9—glaucoma	1.1e-06	7.12e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—glaucoma	1.09e-06	7.08e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP9—glaucoma	1.06e-06	6.92e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CDKN1B—glaucoma	1.06e-06	6.87e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NOS3—glaucoma	1.06e-06	6.87e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CDKN1B—glaucoma	1.06e-06	6.85e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NOS3—glaucoma	1.05e-06	6.83e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP9—glaucoma	1.05e-06	6.83e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTHFR—glaucoma	1.05e-06	6.81e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VEGFA—glaucoma	1.04e-06	6.74e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—glaucoma	1.03e-06	6.71e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—glaucoma	1.03e-06	6.71e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—NOS3—glaucoma	1.02e-06	6.63e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—NOS3—glaucoma	1.01e-06	6.57e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NOS3—glaucoma	1.01e-06	6.53e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—glaucoma	9.99e-07	6.49e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—glaucoma	9.85e-07	6.4e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—glaucoma	9.8e-07	6.37e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—glaucoma	9.78e-07	6.35e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOE—glaucoma	9.76e-07	6.34e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CDKN1B—glaucoma	9.75e-07	6.33e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CAV1—glaucoma	9.67e-07	6.28e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—glaucoma	9.63e-07	6.25e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—glaucoma	9.56e-07	6.21e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—glaucoma	9.56e-07	6.21e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CDKN1B—glaucoma	9.51e-07	6.18e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—glaucoma	9.44e-07	6.13e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—glaucoma	9.34e-07	6.06e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—glaucoma	9.27e-07	6.02e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—glaucoma	9.27e-07	6.02e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—glaucoma	9.27e-07	6.02e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—glaucoma	9.27e-07	6.02e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—glaucoma	9.25e-07	6.01e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CDKN1B—glaucoma	9.17e-07	5.95e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CDKN1B—glaucoma	9.12e-07	5.92e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—glaucoma	9.04e-07	5.87e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—glaucoma	9.03e-07	5.86e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—glaucoma	8.95e-07	5.81e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—glaucoma	8.81e-07	5.72e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—glaucoma	8.8e-07	5.72e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—glaucoma	8.78e-07	5.7e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDKN1B—glaucoma	8.71e-07	5.66e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—glaucoma	8.66e-07	5.62e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—glaucoma	8.49e-07	5.51e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—glaucoma	8.44e-07	5.48e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—glaucoma	8.11e-07	5.26e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—glaucoma	8.07e-07	5.24e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—glaucoma	7.91e-07	5.14e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—glaucoma	7.91e-07	5.14e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—glaucoma	7.85e-07	5.1e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—glaucoma	7.62e-07	4.95e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—glaucoma	7.58e-07	4.92e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—glaucoma	7.44e-07	4.83e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—glaucoma	7.37e-07	4.78e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—glaucoma	7.31e-07	4.75e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAV1—glaucoma	7.3e-07	4.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—glaucoma	7.25e-07	4.71e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—glaucoma	7.23e-07	4.69e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—glaucoma	7.14e-07	4.63e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—glaucoma	7.01e-07	4.55e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—glaucoma	7.01e-07	4.55e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCA1—glaucoma	6.9e-07	4.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1B1—glaucoma	6.9e-07	4.48e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—glaucoma	6.69e-07	4.34e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—glaucoma	6.65e-07	4.32e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—glaucoma	6.63e-07	4.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—glaucoma	6.12e-07	3.98e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—glaucoma	5.98e-07	3.88e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—glaucoma	5.76e-07	3.74e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—glaucoma	5.73e-07	3.72e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—glaucoma	5.52e-07	3.58e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—glaucoma	5.52e-07	3.58e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—glaucoma	5.48e-07	3.56e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—glaucoma	5.05e-07	3.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—glaucoma	4.87e-07	3.17e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—glaucoma	4.54e-07	2.95e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAV1—glaucoma	4.5e-07	2.92e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—glaucoma	3.4e-07	2.21e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—glaucoma	3.11e-07	2.02e-06	CbGpPWpGaD
